Reference - Detail
| RRC ID | 72219 |
|---|---|
| Author | Kunzke T, Hölzl FT, Prade VM, Buck A, Huber K, Feuchtinger A, Ebert K, Zwingenberger G, Geffers R, Hauck SM, Haffner I, Luber B, Lordick F, Walch A. |
| Title | Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2-positive advanced gastric cancer. |
| Journal | Clin Transl Med |
| Volume | 11(9) |
| Pages | e547 |
| Published | 2021-9-1 |
| DOI | 10.1002/ctm2.547 |
| PMID | 34586736 |
| PMC | PMC8473480 |
| MeSH | Antineoplastic Agents, Immunological / pharmacology* Antineoplastic Agents, Immunological / therapeutic use Biopsy Drug Resistance, Neoplasm Humans Metabolome / drug effects* Receptor, ErbB-2 Stomach / pathology Stomach Neoplasms* / drug therapy Stomach Neoplasms* / genetics Stomach Neoplasms* / mortality Stomach Neoplasms* / pathology Trastuzumab / pharmacology* Trastuzumab / therapeutic use |
| Resource | |
| Human and Animal Cells | MKN7(RCB0999) |